Kidney stone pathophysiology
https://https://www.youtube.com/watch?v=uloDkeBOxGQ%7C350}} |
Kidney stone Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Kidney stone pathophysiology On the Web |
American Roentgen Ray Society Images of Kidney stone pathophysiology |
Risk calculators and risk factors for Kidney stone pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Pathophysiology
Pathogenesis
- It is understood that nephrolithiasis is the result of combination of different mechanism responsible for different types of stones:
Calcium stones
- Calcium stones are the most common type of kidney stones.[1]
- Approximately 80% of all calcium stones are calcium oxalate stones.[2]
- The pathophysiology of calcium stones is complex and involves:[3]
- Dietary concerns[4]
- Hypercalciuria
- Hypocitaturia
- Hyperoxaluria
- Hyperuricosuria
- Biomineralization[5]
The following table summarizes major mechanism of stone formation:[6][7][8][9]
Type of stone/Mechanism | Cause | Pathophysiology | Stone composition | Labs | |
---|---|---|---|---|---|
All stones | Low urine volume
(raises production of solutes) |
Reduced intake or increased loss of water | Renal water conservation | All stones |
|
Calcium stones | Hypercalciuria
(raises saturation of calcium salts) |
Absorptive hypercalciuria | Increased absorption in gut | Calcium oxalate or phosphate | Urine calcium concentrations >6 mmol/L (240 mg) per day |
Hyperparathyroidism | Increased absorption in gut and bone release | High concentrations of parathyroid hormone | |||
Immobilization | Bone resorption | High concentrations of vitamin D | |||
Excess of sodium in the diet | Sodium-induced physiological renal calcium leak. Possible component of gut hyperabsorption | Urine sodium concentrations >200 mmol/L per day | |||
Excess of protein or acid in diet | Protein-induced bone loss and renal leak. | ||||
Range of monogenic disorders | Bone loss, gut hyperabsorption, and renal leak in various combinations | ||||
Hypocitraturia
(raises levels of ionised calcium and reduces inhibitor activity against calcium salts) |
Renal tubular acidosis (distal type) | Renal defense of acid-base balance | Calcium phosphate |
| |
High acid load (absence of detectable acidemia) | Physiological hypocitraturia | Calcium oxalate or phosphate |
| ||
Hyperoxaluria
(raises saturation of calcium oxalate) |
Excess of oxalate in diet | Increased delivery of luminal oxalate | Calcium oxalate | Urine oxalate concentrations >70·7 mmol/L per day | |
Bowel pathology | Reduced formation of luminal calcium and calcium-oxalate complex | ||||
Increased production of endogenous oxalate | Primary hyperoxaluria (type 1 and type 2) | ||||
Hyperuricosuria
(sodium urate precipitation causes crystallization of calcium salts) |
High purine intake | Raised production and urinary excretion of sodium and urate |
| ||
Myeloproliferative diseases | |||||
Enzymatic defects | Urine uric acid concentrations >600 mg per day | ||||
Uricosuric drugs | Hypouricaemia | ||||
Genetic primary renal leak | Increased excretion of uric acid | ||||
Uric acid stones | Low urine pH or hyperuricosuria |
|
Titrates urate to poorly soluble uric acid | Uric acid | Urine pH <5·5 |
Cystine stones | Cystinuria | Congenital mutations of dibasic aminoacid transporter subunits rBAT and b0+AT | Renal leak of basic aminoacids | Cystine | Urine concentrations of cystine high (>150 μmol/mmol creatinine) |
Infection stones | Urinary tract infection | Urea-splitting organisms | Production of ammonium and bicarbonate from urea |
|
Genetics
- Nephrolithiasis can be passed on to following generations due to rare causes of hypercalciuria:
- Hereditary distal renal tubular acidosis
- Dent disease
- Bartter syndrome types III and IV
- Autosomal dominant hypocalcemic hypercalciuria
- Familial hypomagnesemia
Associated Conditions
Gross Pathology
- On gross pathology, the characteristic findings of nephrolithiasis are:
- Location = 80% unilateral, usually in calyces, pelvis or bladder
- Size=variable, 2-3 mm usually
- All stones contain an organic matrix of mucoprotein
- Shape:
- Struvite stone= staghorn calculus
-
Nephrolithiasis, Source: Wikimedia commons[10]
-
Staghorn shape of struvite stones, Source: Wikimedia commons[11]
-
Renal calculi, different shapes and sizes, Source: Wikimedia commons[12]
-
Kidney stone with a maximum dimension of 5mm, Source: Wikimedia commons[13]
Microscopic Pathology
- On microscopic histopathological analysis, the characteristic findings of nephrolithiasis are:
- Shapes of different stones/crystals are different:
- Cysteine= hexagonal
- Struvite= coffin lid shape
- Calcium oxalate= pyramid shape
- Calcium oxalate= dumbbell shape
- Uric acid= rectangular/rhomboidal
- Oxalate crystals are highlighted by polarized light
- Foreign body giant cells and macrophages are seen with the stones
- Shapes of different stones/crystals are different:
-
Type of stones. Light microscopy of urine crystals. (A) Hexagonal cystine crystal (200X); (B) coffin-lid shaped struvite crystals (200X); (C) pyramid-shaped calcium oxalate dehydrate crystals (200X); (D) dumbbell-shaped calcium oxalate monohydrate crystal (400X); (E) rectangular uric acid crystals (400X); and (F) rhomboidal uric acid crystals (400X).[14]
-
Deposits of oxalate with variable size and form; they occupy mainly distal tubules. The asterisks indicate proximal tubules, which usually do not contain these crystals, H&E seen with polarized light, X200[15]
-
Medullary interstitial urate crystal deposits in chronic nephropathy by urates as seen after Masson's trichome stain X400[16]
-
Calcium oxalate dihydrate crystals under Scanning Electron Micrograph (SEM) taken at 30 KV. Source: Wikimedia commons[17]
-
Density-dependent color scanning electron micrograph of kidney stone, Source: Wikimedia commons[18]
References
- ↑ Pak CY (December 1991). "Etiology and treatment of urolithiasis". Am. J. Kidney Dis. 18 (6): 624–37. PMID 1962646.
- ↑ Mandel NS, Mandel GS (December 1989). "Urinary tract stone disease in the United States veteran population. II. Geographical analysis of variations in composition". J. Urol. 142 (6): 1516–21. PMID 2585627.
- ↑ Messa P, Marangella M, Paganin L, Codardini M, Cruciatti A, Turrin D, Filiberto Z, Mioni G (September 1997). "Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones". Clin. Sci. 93 (3): 257–63. PMID 9337641.
- ↑ Messa P, Marangella M, Paganin L, Codardini M, Cruciatti A, Turrin D, Filiberto Z, Mioni G (September 1997). "Different dietary calcium intake and relative supersaturation of calcium oxalate in the urine of patients forming renal stones". Clin. Sci. 93 (3): 257–63. PMID 9337641.
- ↑ Umekawa T, Chegini N, Khan SR (January 2002). "Oxalate ions and calcium oxalate crystals stimulate MCP-1 expression by renal epithelial cells". Kidney Int. 61 (1): 105–12. doi:10.1046/j.1523-1755.2002.00106.x. PMID 11786090.
- ↑ Moe, Orson W (2006). "Kidney stones: pathophysiology and medical management". The Lancet. 367 (9507): 333–344. doi:10.1016/S0140-6736(06)68071-9. ISSN 0140-6736.
- ↑ Freitag, Jeffrey; Hruska, Keith (1983). "Pathophysiology of Nephrolithiasis": 523–553. doi:10.1007/978-1-4613-3524-5_16.
- ↑ Gambaro G, Fabris A, Abaterusso C, Cosaro A, Ceol M, Mezzabotta F, Torregrossa R, Tiralongo E, Del Prete D, D'Angelo A, Anglani F (May 2008). "Pathogenesis of nephrolithiasis: recent insight from cell biology and renal pathology". Clin Cases Miner Bone Metab. 5 (2): 107–9. PMID 22460990.
- ↑ Sakhaee, Khashayar (2009). "Recent advances in the pathophysiology of nephrolithiasis". Kidney International. 75 (6): 585–595. doi:10.1038/ki.2008.626. ISSN 0085-2538.
- ↑ By Amadalvarez - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=46706235
- ↑ By H. Zell [GFDL (http://www.gnu.org/copyleft/fdl.html) or CC BY-SA 3.0 (https://creativecommons.org/licenses/by-sa/3.0)], from Wikimedia Commons
- ↑ By Jakupica - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=45324355
- ↑ By RJHall - Own work, Public Domain, https://commons.wikimedia.org/w/index.php?curid=4070842
- ↑ Han H, Segal AM, Seifter JL, Dwyer JT (July 2015). "Nutritional Management of Kidney Stones (Nephrolithiasis)". Clin Nutr Res. 4 (3): 137–52. doi:10.7762/cnr.2015.4.3.137. PMC 4525130. PMID 26251832.
- ↑ http://kidneypathology.com/Imagenes/Diabetes/Oxalato.4.w.jpg
- ↑ http://www.kidneypathology.com/English_version/Diabetes_and_others.html
- ↑ By Kempf EK - Own work, CC BY-SA 3.0, https://commons.wikimedia.org/w/index.php?curid=18036112
- ↑ By Sergio Bertazzo - Own work, CC BY-SA 4.0, https://commons.wikimedia.org/w/index.php?curid=45316797